Back to top

August 2020

  /    /  August

Although the COVID-19 pandemic has prevented on-site attendance at this year’s ASCO meeting (May 29th – May 31st), the global oncology community presented a large range of relevant and potentially practice-changing findings. Highlights of this report include the progress made with regard to various aberrations like ALK, MET, HER2 and RET alterations, as well as EGFR exon 20 insertions and promising drugs in this difficult-to-treat subtype. Moreover, topics including (neo)adjuvant approaches for early stage NSCLC, future perspectives of anti-angiogenic therapy and COVID-19 in the context of thoracic cancer care are covered. Furthermore, the importance of immune checkpoint inhibitors and the determination of unequivocally active combinations of immune agents are addressed. Last but not least, advances in the field of SCLC treatment are presented, valuing immunotherapy in addition to platinum-based chemotherapy, thus bearing a possible new standard-of-care treatment for first-line ES-SCLC. As an additional feature, you will find expert video interviews with Victor Moreno and Helmut Prosch on different conference highlights on memo inOncology website. The memo inOncology Special Issue report is produced by Springer, as a supplement of memo (the Magazine of European Medical Oncology) and sponsored by Boehringer Ingelheim with an unrestricted educational grant. For more information on the memo inOncology

Daniela Dornelles Rosa, José Bines, Gustavo Werutsky, Carlos Henrique Barrios, Eduardo Cronemberger, Geraldo Silva Queiroz, Vladmir C. Cordeiro de Lima, Rufo Freitas‑Júnior, José d’Oliveira Couto, Karla Emerenciano, Heloísa Resende, Susane Crocamo, Tomás Reinert, Brigitte Van Eyil, Yeni Nerón, Vanessa Dybal, Nicolas Lazaretti, Rita de Cassia Costamilan, Diocésio Alves Pinto de Andrade, Clarissa Mathias, Giovana Zerwes Vacaro, Giuliano Borges, Alessandra Morelle, Maira Calef, Carlos Sampaio Filho, Max S. Mano, Facundo Zafaroni, Rafaela Gomes de Jesus, Sergio Daniel Simon Breast Cancer Res Treat (2020). https://doi.org/10.1007/s10549-020-05831-y Full link: https://link.springer.com/article/10.1007%2Fs10549-020-05831-y